ReaGenics is a pioneering brand in the field of plant molecular harvesting. With a vision to optimize the positive benefits of plants for global health and environmental challenges, ReaGenics aims to maximize the potential of nature's gifts. They provide innovative technology that allows for the economical growth of living, organic plant molecules at scale, all without negatively impacting the environment.

The mission of ReaGenics is to stabilize the global supply chain for food, nutraceutical, and pharmaceutical grade plant-sourced molecules. They achieve this through their novel plant cell bioreactor production, which eliminates the need to cultivate plants on an industrial scale for pharma-grade, botanically derived secondary metabolites. ReaGenics has successfully applied their patented technology for multiplication and manipulation of lavender cells, and they are now expanding their reach to cannabis and other plants.

This breakthrough technology enables consistent, controllable, and patentable formulation. Production periods are anticipated to be up to four times faster, and costs considerably cheaper compared to traditional plant cultivation. ReaGenics' bio-reactor production is set to revolutionize the neutraceutical and pharmaceutical industry.

Whether creating powdered biomass for active pharmaceutical ingredients or extracting oils, this innovative approach will change the way we perceive and produce these products. To learn more about ReaGenics and their cutting-edge team, visit their Team Page. ReaGenics is also currently accepting applications for investor and collaborator opportunities, demonstrating their commitment to collaboration and growth in the industry